Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49.8M
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
20.2M
-
Shares change
-
+20.2M
-
Total reported value, excl. options
-
$644M
-
Value change
-
+$644M
-
Put/Call ratio
-
0.66
-
Number of buys
-
86
-
Price
-
$31.88
Significant Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q2 2014
90 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q2 2014.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.2M shares
of 49.8M outstanding shares and own 40.55% of the company stock.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (6.06M shares), IRIDIAN ASSET MANAGEMENT LLC/CT (2.07M shares), VANGUARD GROUP INC (1.37M shares), OPPENHEIMER FUNDS INC (1.09M shares), BlackRock Fund Advisors (818K shares), CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD (802K shares), BlackRock Institutional Trust Company, N.A. (655K shares), State Street Corp (595K shares), FMR LLC (533K shares), and EAGLE ASSET MANAGEMENT INC (468K shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.